Drug interactions
Armodafinil + Conjugated estrogens
Severity: Moderate
Armodafinil and Conjugated estrogens: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Armodafinil is a weak inducer of CYP3A4 and may speed up the breakdown of estrogens. Estradiol-type exposure may fall, which could reduce control of menopausal symptoms or weaken the endometrial protection balance in hormone therapy.
What this interaction means in plain words
Armodafinil and Conjugated estrogens can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Armodafinil induces CYP3A4, increasing the metabolic clearance of estrogen components.
What to do
Monitor for loss of symptom control or breakthrough bleeding and increase the estrogen dose if needed. Reassess the dose when armodafinil is started or stopped.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Armodafinil and Conjugated estrogens, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Armodafinil
Frequently asked questions
Can I take Armodafinil with Conjugated estrogens?
MediHelp rates the interaction as moderate. Armodafinil and Conjugated estrogens can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Armodafinil is a weak inducer of CYP3A4 and may speed up the breakdown of estrogens. Estradiol-type exposure may fall, which could reduce control of menopausal symptoms or weaken the endometrial protection balance in hormone therapy.
How serious is the interaction between Armodafinil and Conjugated estrogens?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for loss of symptom control or breakthrough bleeding and increase the estrogen dose if needed. Reassess the dose when armodafinil is started or stopped.
What other medicines interact with Armodafinil?
MediHelp also lists interactions of Armodafinil with, for example, Avapritinib, Elacestrant, Elbasvir / grazoprevir. The full list is on the Armodafinil page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
